• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.16% Nasdaq Up0.25%

    Nektar Therapeutics (NKTR)

    -NasdaqGS
    11.48 Down 0.02(0.17%) 4:00PM EDT
    |After Hours : 11.48 0.00 (0.00%) 4:22PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 108,801   19,552   132,871   28,513  
    Cost of Revenue8,444  6,298  9,220  5,108  
    Gross Profit 100,357   13,254   123,651   23,405  
    Operating Expenses
    Research Development47,011  38,494  34,200  36,702  
    Selling General and Administrative10,303  12,248  9,130  9,619  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 43,043   (37,488) 80,321   (22,916)
    Income from Continuing Operations
    Total Other Income/Expenses Net211  279  127  96  
    Earnings Before Interest And Taxes43,254  (37,209)80,448  (22,820)
    Interest Expense9,221  9,620  9,595  9,622  
    Income Before Tax34,033  (46,829)70,853  (32,442)
    Income Tax Expense213  (1,146)248  195  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops33,820  (45,683)70,605  (32,637)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 33,820   (45,683) 70,605   (32,637)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 33,820   (45,683) 70,605   (32,637)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.